(RS)-hydroxyzine (Q421937)

hydroxyzine (English)

3 October 2016

chemical formula

C₂₁H₂₇ClN₂O₂

1 reference

hydroxyzine (English)

19 November 2016

canonical SMILES

C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl

1 reference

hydroxyzine (English)

https://www.whocc.no/atc_ddd_index/?code=N05BB01

19 November 2016

defined daily dose

75 milligram

route of administration

oral administration

1 reference

reference URL

75 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=N05BB01

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

hydroxyzine (English)

1 reference

hydroxyzine (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

Drug Indications Extracted from FAERS

13 December 2016

1 reference

significant drug interaction

2 October 2018

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ondansetron

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toremifene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anagrelide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vandetanib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pasireotide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tetrabenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tolterodine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pentamidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mefloquine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

domperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fingolimod

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ivabradine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ivabradine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Histamine receptor H1

subject has role

antagonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7199

Australian pregnancy category A

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Hydroxyzine

16 January 2017

1 reference

Medical Subject Headings

15 March 2018

1 reference

5 March 2018

2 references

5 March 2018

Medical Subject Headings

15 March 2018

hydrOXYzine

Food and Drug Administration

subject named as

Hydroxyzine

1 reference

reference URL

https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project

InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2

2 September 2022

Commons category

Hydroxyzine

0 references

Identifiers

InChI

1 reference

hydroxyzine (English)

19 November 2016

2 references

hydroxyzine (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

68-88-2

2 references

hydroxyzine (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=68-88-2

10 April 2021

1 reference

Hydroxyzine (English)

19 November 2016

2 references

hydroxyzine (English)

19 November 2016

Reaxys registry number

321392

1 reference

hydroxyzine (English)

3 October 2016

ChEBI ID

5818

mapping relation type

2 references

HYDROXYZINE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2

1 reference

HYDROXYZINE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Fac_Eng_Univ_Tokyo-JP003071

1 reference

MassBank accession ID

0 references

MSBNK-Waters-WA002927

0 references

MSBNK-Waters-WA002928

0 references

MSBNK-Waters-WA002929

0 references

MSBNK-Waters-WA002930

0 references

MSBNK-Waters-WA002931

0 references

MSBNK-Waters-WA002932

0 references

SPLASH

splash10-0uxr-4591000000-d2e3424c44feae8a5d9c

0 references

HSDB ID

3098

1 reference

Hazardous Substances Data Bank

28 October 2019

HYDROXYZINE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

hydroxyzine (English)

ECHA Substance Infocard ID

19 November 2016

100.000.630

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.000.630

27 December 2018

Hydroxyzine (English)

quotation

CAS no.: 68-88-2 (English)

0 references

1 reference

World Health Organisation international non-proprietary name numeric ID

Hydroxyzine (English)

publication date

17 November 2015

599

0 references

Guide to Pharmacology Ligand ID

7199

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7199

hydroxyzine (English)

19 November 2016

Hydroxyzine

0 references

0 references

1 reference

hydroxyzine (English)

19 November 2016

DrugBank ID

DB00557

1 reference

Human Metabolome Database ID

HMDB0014697

2 references

based on heuristic

inferred from InChIKey

2 references

hydroxyzine (English)

19 November 2016

MedlinePlus drug identifier

a682866

0 references

PatientsLikeMe treatment ID

0 references

1 reference

hydroxyzine (English)

19 November 2016

0 references

1 reference

1 reference

hydroxyzine (English)

3 October 2016

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

hydroxyzine (English)

3 October 2016

0 references

1 reference

28 October 2013

0 references

Microsoft Academic ID

0 references

0 references

1 reference

26 January 2022

1 reference

1 reference

hydroxyzine (English)